相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation:: An in vitro-in vivo study
B. Feng et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Drug interaction studies: Study design, data analysis, and implications for dosing and labeling
S-M Huang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Role of P-glycoprotein inhibition for drug interactions: Evidence from in vitro and pharmacoepidemiological studies
Sonja Eberl et al.
CLINICAL PHARMACOKINETICS (2007)
Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein
JP Keogh et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport
T Sakaeda et al.
PHARMACEUTICAL RESEARCH (2006)
Scientific perspectives on drug transporters and their role in drug interactions
Lei Zhang et al.
MOLECULAR PHARMACEUTICS (2006)
Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics
SH Wright
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system
CY Wu et al.
PHARMACEUTICAL RESEARCH (2005)
Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine
SG Simonson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
P-glycoprotein: from genomics to mechanism
SV Ambudkar et al.
ONCOGENE (2003)
Impact of drug transporter studies on drug discovery and development
N Mizuno et al.
PHARMACOLOGICAL REVIEWS (2003)
Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction
J Rengelshausen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Drug-drug interaction mediated by inhibition and induction of P-glycoprotein
JH Lin
ADVANCED DRUG DELIVERY REVIEWS (2003)
Drug efflux transporters in the CNS
HY Sun et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Organic anion-transporting polypeptide (OATP) transporter family and drug disposition
RB Kim
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Lopinavir/ritonavir - A review of its use in the management of HIV infection
RS Cvetkovic et al.
DRUGS (2003)
No effect of rosuvastatin on the pharmacokinetics of digoxin in healthy volunteers
PD Martin et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin
A Geick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Oral bioavailability of digoxin is enhanced by talinolol: Evidence for involvement of intestinal P-glycoprotein
K Westphal et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Increased drug delivery to the brain by P-glycoprotein inhibition
AJM Sadeque et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion
RA Boyd et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
分享论文
